Endocrine therapy for breast cancer: a model of hormonal manipulation
Oestrogen receptor (ER) is the driving transcription factor in 70% of breast cancer. Endocrine therapies targeting the ER represent one of the most successful anticancer strategies to date. In the clinic, novel targeted agents are now being exploited in combination with established endocrine therapi...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Published: |
Springer
2018
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/52982/ |